Literature DB >> 12598497

Faecal elastase 1 levels in premature and full term infants.

M Kori1, A Maayan-Metzger, R Shamir, L Sirota, G Dinari.   

Abstract

BACKGROUND: Determination of faecal elastase 1 (FE1) is a simple, relatively inexpensive, non-invasive, highly specific and sensitive test for determining pancreatic function. Secretion of pancreatic enzymes varies during infancy, but there are almost no specific data on the ontogeny of elastase 1 in human babies. AIM: To study FE1 levels in preterm and term babies, and to determine the possible effect of gestational and postconceptual age on these levels.
METHODS: Serial stool samples were collected and tested for FE1 level from 77 premature and full term infants. FE1 levels were determined by a commercially available enzyme linked immunosorbent assay (ELISA) kit.
RESULTS: A total of 232 stool samples were collected from 77 neonates. The FE1 level measured in the first stool sample (meconium) was below normal (200 micro g/g stool) in all samples regardless of gestational age. Sixty three neonates had at least two samples tested for FE1 level. The mean (SD) level of FE1 in sample 1 was 45.9 (51.1) micro g/g stool and was significantly (p < 0.001) lower than in sample 2 (243.0 (164.9) micro g/g stool). The lower the gestational age of the newborn, the more time it took for FE1 to reach normal levels.
CONCLUSIONS: FE1 levels in meconium are low, and studies in meconium should be avoided if pancreatic sufficiency is to be determined. FE1 reaches normal levels by day 3 in term newborns and by 2 weeks in infants born before 28 weeks gestation. Normal levels are reached sooner in infants of more advanced gestational age who start enteral feeding earlier.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598497      PMCID: PMC1721524          DOI: 10.1136/fn.88.2.f106

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  11 in total

Review 1.  Ontogeny of human pancreatic exocrine function.

Authors:  P McClean; L T Weaver
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

2.  Ontogeny of pancreatic exocrine function.

Authors:  S Kolacek; J W Puntis; D R Lloyd; G A Brown; I W Booth
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

3.  Pancreatic elastase 1 in feces of preterm and term infants.

Authors:  K Nissler; I Von Katte; A Huebner; J Henker
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-07       Impact factor: 2.839

4.  Fat absorption in infants of birth weight less than 1,300 gm.

Authors:  L Katz; J R Hamilton
Journal:  J Pediatr       Date:  1974-11       Impact factor: 4.406

5.  Exocrine pancreas function in premature and full term neonates.

Authors:  G Zoppi; G Andreotti; F Pajno-Ferrara; D M Njai; D Gaburro
Journal:  Pediatr Res       Date:  1972-12       Impact factor: 3.756

6.  Human pancreatic enzymes: purification and characterization of a nonelastolytic enzyme, protease E. resembling elastase.

Authors:  P A Mallory; J Travis
Journal:  Biochemistry       Date:  1975-02-25       Impact factor: 3.162

7.  Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test.

Authors:  C Löser; A Möllgaard; U R Fölsch
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

8.  Faecal elastase 1 in children with cystic fibrosis.

Authors:  L Gullo; L Graziano; S Babbini; A Battistini; R Lazzari; R Pezzilli
Journal:  Eur J Pediatr       Date:  1997-10       Impact factor: 3.183

9.  Development of functional responses in human exocrine pancreas.

Authors:  E Lebenthal; P C Lee
Journal:  Pediatrics       Date:  1980-10       Impact factor: 7.124

10.  Sensitivity and specificity of quantitative determination of pancreatic elastase 1 in feces of children.

Authors:  W Soldan; J Henker; C Sprössig
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-01       Impact factor: 2.839

View more
  4 in total

1.  Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

Authors:  Philip M Farrell; Beryl J Rosenstein; Terry B White; Frank J Accurso; Carlo Castellani; Garry R Cutting; Peter R Durie; Vicky A Legrys; John Massie; Richard B Parad; Michael J Rock; Preston W Campbell
Journal:  J Pediatr       Date:  2008-08       Impact factor: 4.406

2.  Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Authors:  Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso
Journal:  J Pediatr       Date:  2009-12       Impact factor: 4.406

3.  Comparative study of preterm infants fed new and existing human milk fortifiers showed favourable markers of gastrointestinal status.

Authors:  Jacques Rigo; Jean-Michel Hascoët; Jean-Charles Picaud; Fabio Mosca; Amandine Rubio; Elie Saliba; Michaël Radkë; Umberto Simeoni; Bernard Guillois; Nicholas P Hays; Mickaël Hartweg; Claude Billeaud; Johannes Spalinger
Journal:  Acta Paediatr       Date:  2019-09-30       Impact factor: 2.299

Review 4.  Development of the human pancreas and its exocrine function.

Authors:  Vijay Mehta; Puanani E Hopson; Yamen Smadi; Samit B Patel; Karoly Horvath; Devendra I Mehta
Journal:  Front Pediatr       Date:  2022-09-29       Impact factor: 3.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.